A Long-Term, Follow-On Safety Study of Four Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons
Clinical trial NCT00002130 · COMPLETED
Trial details
- NCT number
- NCT00002130
- Sponsor
- Otsuka America Pharmaceutical
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.